Human Pluripotent Stem Cell Core

The Human Pluripotent Stem Cell facility continuously evaluates emerging technologies and is now offering both feeder-based and feeder-free cultures in chemically defined mTeSR or in N2/B27 media. The Core is currently offering the generation of iPS cells with two transgene-free methods: 1) using episomes (based on the Yamanaka plasmids); or 2) using Sendai virus.   


  • The Pluripotent Stem Cell Unit provides hESC, hIPS and feeder cell lines.
  • The Human Stem Cell Epigenomics and Reprogramming units provide high-throughput sequencing and bioinformatics analysis services for human stem cell research.
  • The Xenotransplantation Unit provides human stem cells FACS sorting ¬†and transplantation services to test stem cell differentiation potential in vivo.
  • Production of ¬†undifferentiated hES cells and characterization of human pluripotent cells
  • Derivation of new human IPS lines from somatic cells
  • Differentiation of human pluripotent cells into three germ layers
  • Training in maintenance and differentiation of pluripotent stem cells
  • Media/reagents and feeder cells required for pluripotent cell maintenance and differentiation
  • Bioinformatics analysis of high-throughput genomic and epigenomic data obtained from human stem cells
  • Xenotransplantation and FACS sorting

Related Shared Facilities
Related Shared Facilities
no-related-facilities
Center Affiliations
Center Affiliations
no-center-affiliates

Selected Publications

no-publications

Location and Contacts

Human Pluripotent Stem Cell Core Ullmann 925
  • Eric Bouhassira, Ph.D.
    Scientific Director
    718-430-2188